Why Insurance Denies Genetic Testing, and How to Navigate Coverage

Why Insurance Denies Genetic Testing, and How to Navigate Coverage

by DNA Today

Humanities, Social Sciences & Thought Medicine & Health MBPHealth systems and servicesMBPRMedical insurance
🎙 DNA Today 👥 4K 📅 July 31, 2026 ⏱ 34 min 👁 62 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

insurance denialgenetic testingprior authorizationappealscoverage

Summary

This episode of DNA Today launches a special series on the health economics of genetic testing, sponsored by Revvity. Host Kira Dineen is joined by Dr. Madhuri Hegde, Senior Vice President and Chief Scientific Officer at Revvity, and Mackenzie Mosera Derby, a pediatric genetic counselor at UW Health. They discuss the complexities of insurance coverage for genetic testing, including the transition from stacked codes to gene/panel/exome/genome codes, variations in coverage among payers, and the challenges of prior authorization. The conversation covers common reasons for denials, such as the test not changing clinical management, and the importance of documentation and letters of medical necessity. They also explore the roles of laboratories, test utilization committees, and peer-to-peer reviews. The guests highlight the need for collaboration among patients, clinicians, labs, and payers to improve access. They note that coverage is inconsistent, especially for preventive and population-based testing, and that payer policies often lag behind technology. The episode emphasizes the burden on clinicians and labs, and the potential devaluation of genetic services through low-cost self-pay options.

172 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of the information is high for clinicians and patients navigating genetic testing insurance. The guests provide practical insights into the prior authorization process, common denial reasons, and appeal strategies. The argumentation is based on professional experience and is coherent, though it lacks empirical data or citations. The discussion is balanced, acknowledging both the need for insurance limitations and the challenges they pose.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate; the guests are experts, but they do not cite specific studies or data. The sources are primarily anecdotal, but the information aligns with known issues in the field. The title accurately reflects the content. No external sources are provided in the description, so the analysis relies on the expertise of the guests.

136 words

Title / Content Match

The title accurately reflects the content, which focuses on insurance denials for genetic testing and strategies to navigate coverage.

Quality & Reliability

7/10

The podcast features two experts in genetic testing (a chief scientific officer and a genetic counselor) who provide practical insights based on their professional experience. The discussion is anecdotal and lacks direct citations to specific studies or data, but the information is consistent with known challenges in the field. The sponsor (Revvity) may introduce bias, but the content appears balanced.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Contribution & Novelties

The episode provides a comprehensive overview of the insurance landscape for genetic testing, highlighting the inconsistencies and administrative burdens. It offers practical advice for clinicians on navigating prior authorizations and appeals. The discussion on the role of test utilization committees and the need for genetic expertise is valuable.

Pour aller plus loin :

88 words

Radar Profile

The radar profile shows high scores in quantity and quality of information, with moderate technical level and reliability. This indicates a well-rounded discussion with practical insights, though it could benefit from more empirical data and citations.

Reliability 7/10

💬 No comments were provided for analysis.